| scholarly article | Q13442814 |
| P2093 | author name string | Bysani Chandrasekar | |
| Jianbo Wu | |||
| Mao Luo | |||
| Yan Ji | |||
| Neha Goyal | |||
| William P Fay | |||
| Tammy L Strawn | |||
| Zhen Weng | |||
| Philip Fish | |||
| Samantha P Myears | |||
| P2860 | cites work | Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice | Q24310475 |
| The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin | Q24310652 | ||
| Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration | Q24546040 | ||
| TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions | Q28201964 | ||
| Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1 | Q28345650 | ||
| Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes | Q28376780 | ||
| Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis | Q28383719 | ||
| Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway | Q32085275 | ||
| PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice. | Q33627219 | ||
| Molecular mechanisms in intimal hyperplasia | Q33843561 | ||
| Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization | Q33979344 | ||
| Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease | Q33985890 | ||
| Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin | Q34333539 | ||
| Localization of vitronectin in the normal and atherosclerotic human vessel wall | Q34740237 | ||
| A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage | Q35181410 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? | Q36237406 | ||
| Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries | Q37131350 | ||
| LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies | Q37216064 | ||
| Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence | Q37600695 | ||
| Vascular smooth muscle cell proliferation in restenosis | Q37843083 | ||
| Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present). | Q38092174 | ||
| Impaired arterial neointima formation in mice with disruption of the plasminogen gene | Q39776706 | ||
| The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. | Q40582221 | ||
| Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries | Q40724602 | ||
| Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts | Q42128982 | ||
| Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices | Q42425209 | ||
| Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice | Q43653265 | ||
| Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. | Q43909364 | ||
| Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation | Q43939747 | ||
| Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways | Q44728938 | ||
| Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. | Q44850328 | ||
| Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries | Q45880462 | ||
| Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. | Q46420379 | ||
| Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. | Q50523399 | ||
| Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3. | Q51519556 | ||
| A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration. | Q53117289 | ||
| Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein. | Q53460186 | ||
| The effect of plasminogen activator inhibitor type 1 on apoptosis. | Q53519372 | ||
| Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. | Q53622123 | ||
| Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation | Q55670530 | ||
| The Role of PAI-1 and Adiponectin on the Inflammatory State and Energy Balance in Obese Adolescents with Metabolic Syndrome | Q57423553 | ||
| Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 | ||
| Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis | Q70343112 | ||
| Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis | Q71675475 | ||
| PAI-1, obesity, insulin resistance and risk of cardiovascular events | Q73447611 | ||
| Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure | Q73762705 | ||
| Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow | Q73832982 | ||
| Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury | Q73964036 | ||
| Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model | Q78664253 | ||
| Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1 | Q79086796 | ||
| Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis | Q79160721 | ||
| Mechanism of inactivation of plasminogen activator inhibitor-1 by a small molecule inhibitor | Q79717738 | ||
| The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury | Q81711993 | ||
| Inhibition of PAI-1 Via PAI-039 Improves Dermal Wound Closure in Diabetes | Q86895066 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2167-2175 | |
| P577 | publication date | 2016-09-22 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation | |
| P478 | volume | 36 |
| Q47245967 | Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment |
| Q92056401 | Effects of 17β-Estradiol on the Plasminogen Activator System in Vascular Smooth Muscle Cells Treated with Lysophophatidylcholine |
| Q88938326 | Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation |
| Q47657969 | Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin |
| Q90279580 | Protease Activity in Vascular Disease |
| Q57818443 | Reporting Sex and Sex Differences in Preclinical Studies |
| Q88792493 | Thrombotic Regulation From the Endothelial Cell Perspectives |
Search more.